Watson Pharmaceuticals has won US antitrust approval to buy Swiss firm Actavis Inc but only with certain conditions, the Federal Trade Commission (FTC) announced yesterday. Watson Pharmaceuticals ...

For Actavis, the new approval helps it extend its presence in the field – having bought Durata Therapeutics along with its recently approved antibiotic Dalvance (dalbavancin) in October.